Larch Arabinogalactan Joint Research: Ten People, Some Faeces, No Knees

The Oasis Health Journal · Submitted August 6, 2026 · 3:31 PM EDT

By June Mackerel · Edited by Colette Ward

Larch arabinogalactan is a complex polysaccharide extracted from the wood of the larch tree, and it is sold widely as a powder one mixes into beverages for the purpose of supporting joint health, immune function, and general well-being. The label makes it sound as though science has established these things. Science has not established these things. Science has established that ten people donated faecal samples, those samples were placed in dishes with larch arabinogalactan, certain bacteria appeared rather pleased about the arrangement, and the researchers published their findings in a journal you have never heard of.

That is the research.

One imagines the marketing department took that finding and ran some distance with it, perhaps several postcodes, because the available studies on larch arabinogalactan joint support involve no joints, no inflammation, no flexibility, and no humans taking the supplement and reporting whether their knees felt better. What we have instead is microbiology conducted in petri dishes, which is interesting but not quite the same thing as a clinical trial, rather in the way that a photograph of a sandwich is not quite the same thing as lunch.

What the Faeces in the Dish Actually Did

The 2025 study in Microbiome Research Reports is the only piece of research that addresses arabinogalactan's effect on human gut bacteria directly. Ten healthy adults provided faecal samples. The samples were incubated with arabinogalactan for several days. The researchers used 16S rRNA gene sequencing and something called Raman-activated cell sorting, which sounds both expensive and rather difficult to explain at a dinner party, to identify which bacteria responded. One imagines the conversation would be brief.

Bifidobacterium and Gemmiger were consistently enriched across all ten donors. Bifidobacterium longum, in particular, appeared to degrade arabinogalactan efficiently and then share the resulting metabolites with other bacteria that could not break down the fiber themselves. Faecalibacterium prausnitzii, a species often associated with gut health, also grew when arabinogalactan was present. The researchers described this as metabolic cross-feeding, which is a polite way of saying some bacteria ate the fiber and others ate what the first group left behind.

It is all very cooperative. One might even say heartwarming, were it not taking place in a petri dish full of human waste.

The study concluded that arabinogalactan functions as a prebiotic, selectively feeding certain beneficial gut bacteria. That conclusion is supported by the data. The claim that this prebiotic effect translates into joint support, immune tolerance, or connective tissue flexibility is not supported by the data, because the data does not include joints, immune markers, connective tissue, or indeed any part of a human being aside from what was donated into a specimen cup.

The Two Other Studies, Neither of Which Helps

The first study, published in 2022 in the International Journal of Molecular Sciences, is a broad review of probiotics and prebiotics in cardiovascular disease. Arabinogalactan is mentioned once, in a long list of polysaccharides that may influence the gut microbiome. The paper does not test arabinogalactan, does not measure its effects, and does not discuss joints. It is included here because it is one of three studies returned by a search for arabinogalactan and immune or joint health, which tells you how thin the literature is. One might describe it as gossamer. One might also describe it as nonexistent, but gossamer sounds more generous.

The second study, published in January 2025 in Gels, describes the synthesis of hydrogels made from arabinogalactan, kappa-carrageenan, and gold nanoparticles. The hydrogels demonstrated antiradical activity, which means they neutralised free radicals in a test tube. The study measured moisture retention, swelling properties, and elastic modulus. It did not involve humans, bacteria, or any biological system more complex than a beaker.

It is a materials science paper. One hesitates to say it has nothing to do with arabinogalactan supplement immune support, but it has nothing to do with arabinogalactan supplement immune support. It has rather more to do with making a gel that holds moisture and does not fall apart, which is admirable work if one is in the business of making gels.

The Leap from Bacteria to Joints, Unattempted

The theory, presumably, is that feeding beneficial gut bacteria improves systemic inflammation, which in turn improves joint comfort and connective tissue function. That is a reasonable hypothesis. It is also untested. No study has measured whether taking larch arabinogalactan powder daily reduces joint pain, increases flexibility, improves cartilage markers, or changes any inflammation biomarker in living humans with actual joints that bend.

The prebiotic effect is real. Arabinogalactan does feed Bifidobacterium. Bifidobacterium does share metabolites with other species. Some of those species are associated with lower systemic inflammation in observational studies. The chain of reasoning is not absurd. It is merely unsupported by intervention data, which is rather the important bit when one is deciding whether to spend money.

If you are searching for the best larch arabinogalactan supplement for joints, you are searching for evidence that does not exist yet. You are buying a prebiotic fiber with a larch arabinogalactan joint health label, which is not quite the same thing as buying a supplement with joint-health evidence. It is more like buying a book because you enjoy the cover.

What We Know, and What We Rather Obviously Do Not

Larch arabinogalactan is a prebiotic. It selectively feeds certain gut bacteria, particularly Bifidobacterium longum, in ex vivo faecal cultures. Those bacteria share metabolites with other species, some of which are associated with beneficial health effects in separate lines of research. The polysaccharide is generally recognised as safe. It dissolves in water. It has been used in food products for decades without incident, which is a low bar but not an irrelevant one.

None of that establishes efficacy for joint health. The studies on larch extract connective tissue support do not exist. The studies on immune tolerance in the context of joint inflammation do not exist. The studies comparing arabinogalactan supplementation to placebo in humans with osteoarthritis, rheumatoid arthritis, or any other joint condition do not exist. One could convene a conference on the topic and it would be a very short conference, possibly over before the tea arrived.

If one is looking for natural joint flexibility support, one might reasonably consider glucosamine, for which there are over a hundred trials, or curcumin, for which there are dozens, or omega-3 fatty acids, for which there are systematic reviews and meta-analyses. One might also consider larch arabinogalactan, but one would be doing so on the basis of a hypothesis about gut bacteria and systemic inflammation, not on the basis of joint-specific evidence, and one would be doing so with full knowledge that the hypothesis has not been tested in anything with knees.

The powder itself is inoffensive. It mixes into drinks without much ceremony. Some people report mild digestive upset at higher doses, which is common for fermentable fibers and hardly a scandal. The product labels suggest five to ten grams per day, which is within the range used in gut microbiome studies, though not in joint studies, because there are no joint studies.

One might take it as a prebiotic and hope for downstream effects on inflammation. That is not an unreasonable thing to do. It is, however, a thing one does without evidence, which is worth acknowledging before one buys a six-month supply and begins telling people at the gym about it.

This article is education and reporting on published research. It is not medical advice, and nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to your own clinician about your own situation.

Sources

1. Clinical Evidence on the Potential Beneficial Effects of Probiotics and Prebiotics in Cardiovascular Disease, International journal of molecular sciences (2022).
2. AuNP-Containing Hydrogels Based on Arabinogalactan and κ-Carrageenan with Antiradical Activity, Gels (Basel, Switzerland) (2025).
3. Evaluating the prebiotic activity of arabinogalactan on the human gut microbiota using 16S rRNA gene sequencing and Raman-activated cell sorting, Microbiome research reports (2025).